nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP1A1—breast cancer	0.104	0.343	CbGaD
Clonidine—CYP2D6—breast cancer	0.0777	0.255	CbGaD
Clonidine—SLC22A3—Melphalan—breast cancer	0.0754	0.179	CbGbCtD
Clonidine—CYP3A4—breast cancer	0.0666	0.219	CbGaD
Clonidine—ABCB1—breast cancer	0.0554	0.182	CbGaD
Clonidine—CYP1A1—Toremifene—breast cancer	0.0367	0.0871	CbGbCtD
Clonidine—SLC22A3—Irinotecan—breast cancer	0.0255	0.0605	CbGbCtD
Clonidine—CYP1A2—Anastrozole—breast cancer	0.0179	0.0425	CbGbCtD
Clonidine—CYP1A2—Toremifene—breast cancer	0.0164	0.0389	CbGbCtD
Clonidine—CYP3A5—Lapatinib—breast cancer	0.0161	0.0381	CbGbCtD
Clonidine—ABCB1—Toremifene—breast cancer	0.0143	0.034	CbGbCtD
Clonidine—CYP1A1—Tamoxifen—breast cancer	0.0134	0.0318	CbGbCtD
Clonidine—CYP3A4—Exemestane—breast cancer	0.0124	0.0294	CbGbCtD
Clonidine—CYP2D6—Idarubicin—breast cancer	0.0112	0.0266	CbGbCtD
Clonidine—CYP3A4—Letrozole—breast cancer	0.0105	0.025	CbGbCtD
Clonidine—ABCB1—Lapatinib—breast cancer	0.0105	0.0248	CbGbCtD
Clonidine—CYP3A4—Anastrozole—breast cancer	0.00939	0.0223	CbGbCtD
Clonidine—CYP3A4—Toremifene—breast cancer	0.00859	0.0204	CbGbCtD
Clonidine—CYP3A5—Tamoxifen—breast cancer	0.00804	0.0191	CbGbCtD
Clonidine—CYP3A4—Fulvestrant—breast cancer	0.00798	0.0189	CbGbCtD
Clonidine—CYP3A4—Thiotepa—breast cancer	0.00711	0.0169	CbGbCtD
Clonidine—CYP3A4—Ixabepilone—breast cancer	0.00651	0.0154	CbGbCtD
Clonidine—CYP3A4—Lapatinib—breast cancer	0.00626	0.0149	CbGbCtD
Clonidine—CYP3A5—Paclitaxel—breast cancer	0.00626	0.0149	CbGbCtD
Clonidine—CYP3A5—Irinotecan—breast cancer	0.00618	0.0147	CbGbCtD
Clonidine—CYP1A2—Tamoxifen—breast cancer	0.00599	0.0142	CbGbCtD
Clonidine—ABCB1—Vinorelbine—breast cancer	0.0058	0.0138	CbGbCtD
Clonidine—CYP2D6—Vinorelbine—breast cancer	0.00546	0.013	CbGbCtD
Clonidine—ABCB1—Tamoxifen—breast cancer	0.00523	0.0124	CbGbCtD
Clonidine—ABCB1—Mitoxantrone—breast cancer	0.0051	0.0121	CbGbCtD
Clonidine—CYP2D6—Tamoxifen—breast cancer	0.00493	0.0117	CbGbCtD
Clonidine—CYP3A4—Raloxifene—breast cancer	0.00475	0.0113	CbGbCtD
Clonidine—CYP3A5—Docetaxel—breast cancer	0.00453	0.0107	CbGbCtD
Clonidine—ABCB1—Gemcitabine—breast cancer	0.00451	0.0107	CbGbCtD
Clonidine—CYP1A2—Fluorouracil—breast cancer	0.00441	0.0105	CbGbCtD
Clonidine—ABCB1—Paclitaxel—breast cancer	0.00407	0.00967	CbGbCtD
Clonidine—ABCB1—Irinotecan—breast cancer	0.00402	0.00954	CbGbCtD
Clonidine—ABCB1—Vinblastine—breast cancer	0.00357	0.00848	CbGbCtD
Clonidine—CYP3A4—Vinorelbine—breast cancer	0.00347	0.00825	CbGbCtD
Clonidine—CYP2D6—Vinblastine—breast cancer	0.00337	0.00799	CbGbCtD
Clonidine—CYP3A4—Tamoxifen—breast cancer	0.00314	0.00744	CbGbCtD
Clonidine—CYP3A4—Mitoxantrone—breast cancer	0.00306	0.00726	CbGbCtD
Clonidine—ABCB1—Docetaxel—breast cancer	0.00295	0.00699	CbGbCtD
Clonidine—CYP3A4—Paclitaxel—breast cancer	0.00244	0.00579	CbGbCtD
Clonidine—CYP3A4—Irinotecan—breast cancer	0.00241	0.00572	CbGbCtD
Clonidine—ABCB1—Doxorubicin—breast cancer	0.0022	0.00521	CbGbCtD
Clonidine—CYP3A4—Vinblastine—breast cancer	0.00214	0.00508	CbGbCtD
Clonidine—ABCB1—Methotrexate—breast cancer	0.00213	0.00505	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—breast cancer	0.00207	0.00491	CbGbCtD
Clonidine—CYP3A4—Docetaxel—breast cancer	0.00176	0.00419	CbGbCtD
Clonidine—NISCH—mammary gland—breast cancer	0.00141	0.0441	CbGeAlD
Clonidine—CYP3A4—Doxorubicin—breast cancer	0.00132	0.00312	CbGbCtD
Clonidine—NISCH—nipple—breast cancer	0.00117	0.0365	CbGeAlD
Clonidine—NISCH—Paclitaxel—Docetaxel—breast cancer	0.000935	0.359	CbGdCrCtD
Clonidine—SLC22A4—mammary gland—breast cancer	0.000934	0.0292	CbGeAlD
Clonidine—SLC22A3—nipple—breast cancer	0.000703	0.022	CbGeAlD
Clonidine—ADRA1D—epithelium—breast cancer	0.000656	0.0205	CbGeAlD
Clonidine—NISCH—uterus—breast cancer	0.00065	0.0203	CbGeAlD
Clonidine—NISCH—Vincristine—Vinorelbine—breast cancer	0.000643	0.246	CbGdCrCtD
Clonidine—NISCH—pituitary gland—breast cancer	0.000638	0.02	CbGeAlD
Clonidine—NISCH—adipose tissue—breast cancer	0.000636	0.0199	CbGeAlD
Clonidine—SLC22A5—mammary gland—breast cancer	0.000618	0.0193	CbGeAlD
Clonidine—SLC22A3—embryo—breast cancer	0.00058	0.0181	CbGeAlD
Clonidine—NISCH—adrenal gland—breast cancer	0.00057	0.0178	CbGeAlD
Clonidine—NISCH—bone marrow—breast cancer	0.000552	0.0172	CbGeAlD
Clonidine—ADRA2C—nipple—breast cancer	0.000534	0.0167	CbGeAlD
Clonidine—NISCH—female gonad—breast cancer	0.000532	0.0166	CbGeAlD
Clonidine—NISCH—Vinblastine—Vinorelbine—breast cancer	0.000517	0.198	CbGdCrCtD
Clonidine—NISCH—Vincristine—Vinblastine—breast cancer	0.000514	0.197	CbGdCrCtD
Clonidine—SLC22A5—nipple—breast cancer	0.000511	0.016	CbGeAlD
Clonidine—ADRA1D—female reproductive system—breast cancer	0.000488	0.0152	CbGeAlD
Clonidine—SLC22A4—endometrium—breast cancer	0.000466	0.0146	CbGeAlD
Clonidine—CYP1A2—nipple—breast cancer	0.000463	0.0145	CbGeAlD
Clonidine—CYP1A1—nipple—breast cancer	0.000457	0.0143	CbGeAlD
Clonidine—Diclofenac—ABCC1—breast cancer	0.000431	0.269	CrCbGaD
Clonidine—ADRA2A—nipple—breast cancer	0.000426	0.0133	CbGeAlD
Clonidine—SLC22A3—endometrium—breast cancer	0.000424	0.0133	CbGeAlD
Clonidine—SLC22A4—pituitary gland—breast cancer	0.000422	0.0132	CbGeAlD
Clonidine—SLC22A4—adipose tissue—breast cancer	0.00042	0.0131	CbGeAlD
Clonidine—ADRA1D—endocrine gland—breast cancer	0.000413	0.0129	CbGeAlD
Clonidine—SLC22A1—adipose tissue—breast cancer	0.0004	0.0125	CbGeAlD
Clonidine—SLC22A4—female reproductive system—breast cancer	0.000386	0.0121	CbGeAlD
Clonidine—SLC22A3—adipose tissue—breast cancer	0.000382	0.012	CbGeAlD
Clonidine—Diclofenac—CXCL8—breast cancer	0.000382	0.238	CrCbGaD
Clonidine—ADRA1A—epithelium—breast cancer	0.000377	0.0118	CbGeAlD
Clonidine—SLC22A4—adrenal gland—breast cancer	0.000377	0.0118	CbGeAlD
Clonidine—SLC22A4—bone marrow—breast cancer	0.000365	0.0114	CbGeAlD
Clonidine—SLC22A3—female reproductive system—breast cancer	0.000352	0.011	CbGeAlD
Clonidine—SLC22A3—adrenal gland—breast cancer	0.000343	0.0107	CbGeAlD
Clonidine—NISCH—lymph node—breast cancer	0.000342	0.0107	CbGeAlD
Clonidine—SLC22A5—skin of body—breast cancer	0.000327	0.0102	CbGeAlD
Clonidine—ADRA2C—endometrium—breast cancer	0.000322	0.0101	CbGeAlD
Clonidine—SLC22A3—female gonad—breast cancer	0.00032	0.01	CbGeAlD
Clonidine—SLC22A1—endocrine gland—breast cancer	0.000311	0.00973	CbGeAlD
Clonidine—SLC22A5—endometrium—breast cancer	0.000309	0.00965	CbGeAlD
Clonidine—CYP1A1—epithelium—breast cancer	0.000308	0.00961	CbGeAlD
Clonidine—ADRA1A—adipose tissue—breast cancer	0.000305	0.00953	CbGeAlD
Clonidine—SLC6A2—female reproductive system—breast cancer	0.000301	0.00942	CbGeAlD
Clonidine—SLC22A3—endocrine gland—breast cancer	0.000298	0.0093	CbGeAlD
Clonidine—ADRA2C—uterus—breast cancer	0.000297	0.00928	CbGeAlD
Clonidine—SLC6A2—adrenal gland—breast cancer	0.000294	0.00919	CbGeAlD
Clonidine—CYP1A1—skin of body—breast cancer	0.000292	0.00914	CbGeAlD
Clonidine—ADRA2C—pituitary gland—breast cancer	0.000292	0.00911	CbGeAlD
Clonidine—ADRA2C—adipose tissue—breast cancer	0.00029	0.00908	CbGeAlD
Clonidine—SLC22A5—pituitary gland—breast cancer	0.000279	0.00873	CbGeAlD
Clonidine—SLC22A5—adipose tissue—breast cancer	0.000278	0.00869	CbGeAlD
Clonidine—ADRA1A—adrenal gland—breast cancer	0.000273	0.00854	CbGeAlD
Clonidine—ADRA2C—adrenal gland—breast cancer	0.00026	0.00814	CbGeAlD
Clonidine—ADRA2A—endometrium—breast cancer	0.000257	0.00804	CbGeAlD
Clonidine—SLC22A5—female reproductive system—breast cancer	0.000256	0.00799	CbGeAlD
Clonidine—SLC6A2—endocrine gland—breast cancer	0.000255	0.00797	CbGeAlD
Clonidine—CYP1A1—uterus—breast cancer	0.000254	0.00794	CbGeAlD
Clonidine—SLC22A5—adrenal gland—breast cancer	0.000249	0.0078	CbGeAlD
Clonidine—CYP1A1—adipose tissue—breast cancer	0.000249	0.00777	CbGeAlD
Clonidine—CYP3A5—adipose tissue—breast cancer	0.000243	0.0076	CbGeAlD
Clonidine—ADRA2C—female gonad—breast cancer	0.000243	0.00759	CbGeAlD
Clonidine—ADRA1A—endocrine gland—breast cancer	0.000237	0.00741	CbGeAlD
Clonidine—ADRA2A—uterus—breast cancer	0.000237	0.00741	CbGeAlD
Clonidine—ADRA2A—pituitary gland—breast cancer	0.000233	0.00727	CbGeAlD
Clonidine—SLC22A5—female gonad—breast cancer	0.000233	0.00727	CbGeAlD
Clonidine—ADRA2A—adipose tissue—breast cancer	0.000232	0.00724	CbGeAlD
Clonidine—CYP1A1—female reproductive system—breast cancer	0.000228	0.00714	CbGeAlD
Clonidine—SLC22A4—lymph node—breast cancer	0.000226	0.00706	CbGeAlD
Clonidine—ADRA2A—female reproductive system—breast cancer	0.000213	0.00666	CbGeAlD
Clonidine—CYP1A1—female gonad—breast cancer	0.000208	0.0065	CbGeAlD
Clonidine—ADRA2A—adrenal gland—breast cancer	0.000208	0.0065	CbGeAlD
Clonidine—SLC22A3—lymph node—breast cancer	0.000206	0.00643	CbGeAlD
Clonidine—CYP3A5—female gonad—breast cancer	0.000203	0.00635	CbGeAlD
Clonidine—CYP1A2—endocrine gland—breast cancer	0.000196	0.00613	CbGeAlD
Clonidine—ABCB1—embryo—breast cancer	0.000196	0.00612	CbGeAlD
Clonidine—Diclofenac—PTGS1—breast cancer	0.000195	0.121	CrCbGaD
Clonidine—ADRA2A—female gonad—breast cancer	0.000194	0.00606	CbGeAlD
Clonidine—CYP1A1—endocrine gland—breast cancer	0.000193	0.00604	CbGeAlD
Clonidine—CYP3A5—endocrine gland—breast cancer	0.000189	0.00591	CbGeAlD
Clonidine—ADRA2A—endocrine gland—breast cancer	0.00018	0.00563	CbGeAlD
Clonidine—Diclofenac—CYP1A1—breast cancer	0.000178	0.111	CrCbGaD
Clonidine—SLC6A2—lymph node—breast cancer	0.000176	0.00551	CbGeAlD
Clonidine—CYP3A4—female reproductive system—breast cancer	0.000168	0.00524	CbGeAlD
Clonidine—CYP2D6—female reproductive system—breast cancer	0.000165	0.00516	CbGeAlD
Clonidine—ABCB1—epithelium—breast cancer	0.00016	0.00499	CbGeAlD
Clonidine—ADRA2C—lymph node—breast cancer	0.000156	0.00488	CbGeAlD
Clonidine—CYP2D6—female gonad—breast cancer	0.00015	0.00469	CbGeAlD
Clonidine—SLC22A5—lymph node—breast cancer	0.00015	0.00467	CbGeAlD
Clonidine—ABCB1—endometrium—breast cancer	0.000143	0.00448	CbGeAlD
Clonidine—CYP3A4—endocrine gland—breast cancer	0.000142	0.00443	CbGeAlD
Clonidine—CYP2D6—endocrine gland—breast cancer	0.00014	0.00436	CbGeAlD
Clonidine—CYP1A1—lymph node—breast cancer	0.000134	0.00418	CbGeAlD
Clonidine—ABCB1—uterus—breast cancer	0.000132	0.00413	CbGeAlD
Clonidine—ABCB1—pituitary gland—breast cancer	0.00013	0.00405	CbGeAlD
Clonidine—ABCB1—adipose tissue—breast cancer	0.000129	0.00404	CbGeAlD
Clonidine—ADRA2A—lymph node—breast cancer	0.000125	0.00389	CbGeAlD
Clonidine—ABCB1—female reproductive system—breast cancer	0.000119	0.00371	CbGeAlD
Clonidine—ABCB1—adrenal gland—breast cancer	0.000116	0.00362	CbGeAlD
Clonidine—Diclofenac—CYP3A4—breast cancer	0.000114	0.0708	CrCbGaD
Clonidine—ABCB1—bone marrow—breast cancer	0.000112	0.0035	CbGeAlD
Clonidine—Diclofenac—PTGS2—breast cancer	0.000111	0.0694	CrCbGaD
Clonidine—ABCB1—female gonad—breast cancer	0.000108	0.00338	CbGeAlD
Clonidine—ABCB1—endocrine gland—breast cancer	0.0001	0.00314	CbGeAlD
Clonidine—Diclofenac—ALB—breast cancer	9.92e-05	0.0618	CrCbGaD
Clonidine—Diclofenac—ABCB1—breast cancer	9.46e-05	0.059	CrCbGaD
Clonidine—ABCB1—lymph node—breast cancer	6.94e-05	0.00217	CbGeAlD
Clonidine—Dizziness—Fluorouracil—breast cancer	3.8e-05	0.000257	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—breast cancer	3.8e-05	0.000257	CcSEcCtD
Clonidine—Rash—Mitoxantrone—breast cancer	3.79e-05	0.000256	CcSEcCtD
Clonidine—Rash—Irinotecan—breast cancer	3.79e-05	0.000256	CcSEcCtD
Clonidine—Dermatitis—Irinotecan—breast cancer	3.78e-05	0.000256	CcSEcCtD
Clonidine—Dermatitis—Mitoxantrone—breast cancer	3.78e-05	0.000256	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Docetaxel—breast cancer	3.78e-05	0.000256	CcSEcCtD
Clonidine—Headache—Mitoxantrone—breast cancer	3.76e-05	0.000255	CcSEcCtD
Clonidine—Headache—Irinotecan—breast cancer	3.76e-05	0.000255	CcSEcCtD
Clonidine—Hypotension—Capecitabine—breast cancer	3.76e-05	0.000254	CcSEcCtD
Clonidine—Insomnia—Docetaxel—breast cancer	3.76e-05	0.000254	CcSEcCtD
Clonidine—Paraesthesia—Docetaxel—breast cancer	3.73e-05	0.000252	CcSEcCtD
Clonidine—Alopecia—Methotrexate—breast cancer	3.72e-05	0.000252	CcSEcCtD
Clonidine—Vomiting—Gemcitabine—breast cancer	3.72e-05	0.000252	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—breast cancer	3.71e-05	0.000251	CcSEcCtD
Clonidine—Dyspnoea—Docetaxel—breast cancer	3.7e-05	0.000251	CcSEcCtD
Clonidine—Somnolence—Docetaxel—breast cancer	3.69e-05	0.00025	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—breast cancer	3.69e-05	0.00025	CcSEcCtD
Clonidine—Rash—Gemcitabine—breast cancer	3.69e-05	0.00025	CcSEcCtD
Clonidine—Dermatitis—Gemcitabine—breast cancer	3.69e-05	0.000249	CcSEcCtD
Clonidine—Eye disorder—Epirubicin—breast cancer	3.68e-05	0.000249	CcSEcCtD
Clonidine—Tinnitus—Epirubicin—breast cancer	3.68e-05	0.000249	CcSEcCtD
Clonidine—Erythema—Methotrexate—breast cancer	3.67e-05	0.000248	CcSEcCtD
Clonidine—Headache—Gemcitabine—breast cancer	3.67e-05	0.000248	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Capecitabine—breast cancer	3.66e-05	0.000248	CcSEcCtD
Clonidine—Cardiac disorder—Epirubicin—breast cancer	3.66e-05	0.000248	CcSEcCtD
Clonidine—Vomiting—Fluorouracil—breast cancer	3.66e-05	0.000248	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—breast cancer	3.66e-05	0.000247	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—breast cancer	3.65e-05	0.000247	CcSEcCtD
Clonidine—Insomnia—Capecitabine—breast cancer	3.64e-05	0.000246	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—breast cancer	3.63e-05	0.000246	CcSEcCtD
Clonidine—Rash—Fluorouracil—breast cancer	3.63e-05	0.000245	CcSEcCtD
Clonidine—Dermatitis—Fluorouracil—breast cancer	3.62e-05	0.000245	CcSEcCtD
Clonidine—Paraesthesia—Capecitabine—breast cancer	3.61e-05	0.000244	CcSEcCtD
Clonidine—Decreased appetite—Docetaxel—breast cancer	3.61e-05	0.000244	CcSEcCtD
Clonidine—Hypersensitivity—Paclitaxel—breast cancer	3.61e-05	0.000244	CcSEcCtD
Clonidine—Headache—Fluorouracil—breast cancer	3.6e-05	0.000244	CcSEcCtD
Clonidine—Gastrointestinal disorder—Docetaxel—breast cancer	3.59e-05	0.000243	CcSEcCtD
Clonidine—Dyspnoea—Capecitabine—breast cancer	3.58e-05	0.000243	CcSEcCtD
Clonidine—Fatigue—Docetaxel—breast cancer	3.58e-05	0.000242	CcSEcCtD
Clonidine—Angiopathy—Epirubicin—breast cancer	3.58e-05	0.000242	CcSEcCtD
Clonidine—Nausea—Irinotecan—breast cancer	3.57e-05	0.000241	CcSEcCtD
Clonidine—Nausea—Mitoxantrone—breast cancer	3.57e-05	0.000241	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—breast cancer	3.55e-05	0.00024	CcSEcCtD
Clonidine—Constipation—Docetaxel—breast cancer	3.55e-05	0.00024	CcSEcCtD
Clonidine—Pain—Docetaxel—breast cancer	3.55e-05	0.00024	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—breast cancer	3.52e-05	0.000238	CcSEcCtD
Clonidine—Asthenia—Paclitaxel—breast cancer	3.52e-05	0.000238	CcSEcCtD
Clonidine—Decreased appetite—Capecitabine—breast cancer	3.49e-05	0.000236	CcSEcCtD
Clonidine—Alopecia—Epirubicin—breast cancer	3.48e-05	0.000236	CcSEcCtD
Clonidine—Nausea—Gemcitabine—breast cancer	3.48e-05	0.000235	CcSEcCtD
Clonidine—Gastrointestinal disorder—Capecitabine—breast cancer	3.47e-05	0.000235	CcSEcCtD
Clonidine—Fatigue—Capecitabine—breast cancer	3.47e-05	0.000235	CcSEcCtD
Clonidine—Pruritus—Paclitaxel—breast cancer	3.47e-05	0.000235	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—breast cancer	3.46e-05	0.000234	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—breast cancer	3.45e-05	0.000234	CcSEcCtD
Clonidine—Constipation—Capecitabine—breast cancer	3.44e-05	0.000233	CcSEcCtD
Clonidine—Pain—Capecitabine—breast cancer	3.44e-05	0.000233	CcSEcCtD
Clonidine—Erythema—Epirubicin—breast cancer	3.43e-05	0.000232	CcSEcCtD
Clonidine—Feeling abnormal—Docetaxel—breast cancer	3.42e-05	0.000232	CcSEcCtD
Clonidine—Nausea—Fluorouracil—breast cancer	3.42e-05	0.000231	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—breast cancer	3.41e-05	0.000231	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—breast cancer	3.4e-05	0.00023	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—breast cancer	3.4e-05	0.00023	CcSEcCtD
Clonidine—Gastrointestinal pain—Docetaxel—breast cancer	3.4e-05	0.00023	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—breast cancer	3.39e-05	0.000229	CcSEcCtD
Clonidine—Tension—Epirubicin—breast cancer	3.37e-05	0.000228	CcSEcCtD
Clonidine—Diarrhoea—Paclitaxel—breast cancer	3.35e-05	0.000227	CcSEcCtD
Clonidine—Nervousness—Epirubicin—breast cancer	3.33e-05	0.000226	CcSEcCtD
Clonidine—Feeling abnormal—Capecitabine—breast cancer	3.31e-05	0.000224	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—breast cancer	3.31e-05	0.000224	CcSEcCtD
Clonidine—Malaise—Methotrexate—breast cancer	3.31e-05	0.000224	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—breast cancer	3.3e-05	0.000223	CcSEcCtD
Clonidine—Gastrointestinal pain—Capecitabine—breast cancer	3.29e-05	0.000222	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—breast cancer	3.29e-05	0.000222	CcSEcCtD
Clonidine—Abdominal pain—Docetaxel—breast cancer	3.28e-05	0.000222	CcSEcCtD
Clonidine—Body temperature increased—Docetaxel—breast cancer	3.28e-05	0.000222	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—breast cancer	3.26e-05	0.00022	CcSEcCtD
Clonidine—Dizziness—Paclitaxel—breast cancer	3.24e-05	0.000219	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—breast cancer	3.23e-05	0.000219	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—breast cancer	3.22e-05	0.000218	CcSEcCtD
Clonidine—Cough—Methotrexate—breast cancer	3.2e-05	0.000217	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—breast cancer	3.2e-05	0.000216	CcSEcCtD
Clonidine—Urticaria—Capecitabine—breast cancer	3.19e-05	0.000216	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—breast cancer	3.18e-05	0.000215	CcSEcCtD
Clonidine—Body temperature increased—Capecitabine—breast cancer	3.18e-05	0.000215	CcSEcCtD
Clonidine—Abdominal pain—Capecitabine—breast cancer	3.18e-05	0.000215	CcSEcCtD
Clonidine—Erythema—Doxorubicin—breast cancer	3.18e-05	0.000215	CcSEcCtD
Clonidine—Agitation—Epirubicin—breast cancer	3.15e-05	0.000213	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—breast cancer	3.12e-05	0.000211	CcSEcCtD
Clonidine—Chest pain—Methotrexate—breast cancer	3.12e-05	0.000211	CcSEcCtD
Clonidine—Tension—Doxorubicin—breast cancer	3.12e-05	0.000211	CcSEcCtD
Clonidine—Vomiting—Paclitaxel—breast cancer	3.11e-05	0.000211	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.1e-05	0.00021	CcSEcCtD
Clonidine—Malaise—Epirubicin—breast cancer	3.09e-05	0.000209	CcSEcCtD
Clonidine—Rash—Paclitaxel—breast cancer	3.09e-05	0.000209	CcSEcCtD
Clonidine—Dermatitis—Paclitaxel—breast cancer	3.09e-05	0.000209	CcSEcCtD
Clonidine—Discomfort—Methotrexate—breast cancer	3.08e-05	0.000209	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—breast cancer	3.08e-05	0.000209	CcSEcCtD
Clonidine—Syncope—Epirubicin—breast cancer	3.08e-05	0.000208	CcSEcCtD
Clonidine—Headache—Paclitaxel—breast cancer	3.07e-05	0.000208	CcSEcCtD
Clonidine—Hypersensitivity—Docetaxel—breast cancer	3.06e-05	0.000207	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—breast cancer	3.05e-05	0.000207	CcSEcCtD
Clonidine—Palpitations—Epirubicin—breast cancer	3.03e-05	0.000205	CcSEcCtD
Clonidine—Confusional state—Methotrexate—breast cancer	3.02e-05	0.000204	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—breast cancer	3.02e-05	0.000204	CcSEcCtD
Clonidine—Cough—Epirubicin—breast cancer	2.99e-05	0.000203	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—breast cancer	2.99e-05	0.000202	CcSEcCtD
Clonidine—Asthenia—Docetaxel—breast cancer	2.98e-05	0.000202	CcSEcCtD
Clonidine—Infection—Methotrexate—breast cancer	2.97e-05	0.000201	CcSEcCtD
Clonidine—Hypersensitivity—Capecitabine—breast cancer	2.96e-05	0.0002	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—breast cancer	2.95e-05	0.000199	CcSEcCtD
Clonidine—Pruritus—Docetaxel—breast cancer	2.94e-05	0.000199	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—breast cancer	2.94e-05	0.000199	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—breast cancer	2.93e-05	0.000198	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—breast cancer	2.92e-05	0.000198	CcSEcCtD
Clonidine—Chest pain—Epirubicin—breast cancer	2.92e-05	0.000198	CcSEcCtD
Clonidine—Agitation—Doxorubicin—breast cancer	2.92e-05	0.000197	CcSEcCtD
Clonidine—Anxiety—Epirubicin—breast cancer	2.91e-05	0.000197	CcSEcCtD
Clonidine—Nausea—Paclitaxel—breast cancer	2.91e-05	0.000197	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—breast cancer	2.91e-05	0.000197	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.9e-05	0.000196	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—breast cancer	2.89e-05	0.000196	CcSEcCtD
Clonidine—Discomfort—Epirubicin—breast cancer	2.89e-05	0.000195	CcSEcCtD
Clonidine—Asthenia—Capecitabine—breast cancer	2.88e-05	0.000195	CcSEcCtD
Clonidine—Malaise—Doxorubicin—breast cancer	2.86e-05	0.000194	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—breast cancer	2.86e-05	0.000193	CcSEcCtD
Clonidine—Anorexia—Methotrexate—breast cancer	2.85e-05	0.000193	CcSEcCtD
Clonidine—Syncope—Doxorubicin—breast cancer	2.85e-05	0.000193	CcSEcCtD
Clonidine—Pruritus—Capecitabine—breast cancer	2.84e-05	0.000192	CcSEcCtD
Clonidine—Diarrhoea—Docetaxel—breast cancer	2.84e-05	0.000192	CcSEcCtD
Clonidine—Confusional state—Epirubicin—breast cancer	2.82e-05	0.000191	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—breast cancer	2.81e-05	0.00019	CcSEcCtD
Clonidine—Oedema—Epirubicin—breast cancer	2.8e-05	0.00019	CcSEcCtD
Clonidine—Hypotension—Methotrexate—breast cancer	2.8e-05	0.000189	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—breast cancer	2.79e-05	0.000189	CcSEcCtD
Clonidine—Infection—Epirubicin—breast cancer	2.78e-05	0.000188	CcSEcCtD
Clonidine—Cough—Doxorubicin—breast cancer	2.77e-05	0.000187	CcSEcCtD
Clonidine—Shock—Epirubicin—breast cancer	2.76e-05	0.000186	CcSEcCtD
Clonidine—Diarrhoea—Capecitabine—breast cancer	2.75e-05	0.000186	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—breast cancer	2.75e-05	0.000186	CcSEcCtD
Clonidine—Dizziness—Docetaxel—breast cancer	2.75e-05	0.000186	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—breast cancer	2.74e-05	0.000186	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—breast cancer	2.73e-05	0.000185	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.73e-05	0.000185	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—breast cancer	2.72e-05	0.000184	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—breast cancer	2.71e-05	0.000183	CcSEcCtD
Clonidine—Insomnia—Methotrexate—breast cancer	2.71e-05	0.000183	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—breast cancer	2.7e-05	0.000183	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—breast cancer	2.7e-05	0.000183	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—breast cancer	2.69e-05	0.000182	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—breast cancer	2.69e-05	0.000182	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.68e-05	0.000182	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—breast cancer	2.67e-05	0.000181	CcSEcCtD
Clonidine—Anorexia—Epirubicin—breast cancer	2.67e-05	0.000181	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—breast cancer	2.67e-05	0.000181	CcSEcCtD
Clonidine—Somnolence—Methotrexate—breast cancer	2.66e-05	0.00018	CcSEcCtD
Clonidine—Dizziness—Capecitabine—breast cancer	2.66e-05	0.00018	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—breast cancer	2.64e-05	0.000179	CcSEcCtD
Clonidine—Vomiting—Docetaxel—breast cancer	2.64e-05	0.000179	CcSEcCtD
Clonidine—Rash—Docetaxel—breast cancer	2.62e-05	0.000177	CcSEcCtD
Clonidine—Hypotension—Epirubicin—breast cancer	2.62e-05	0.000177	CcSEcCtD
Clonidine—Dermatitis—Docetaxel—breast cancer	2.62e-05	0.000177	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—breast cancer	2.61e-05	0.000177	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—breast cancer	2.6e-05	0.000176	CcSEcCtD
Clonidine—Headache—Docetaxel—breast cancer	2.6e-05	0.000176	CcSEcCtD
Clonidine—Oedema—Doxorubicin—breast cancer	2.59e-05	0.000175	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—breast cancer	2.58e-05	0.000175	CcSEcCtD
Clonidine—Fatigue—Methotrexate—breast cancer	2.58e-05	0.000175	CcSEcCtD
Clonidine—Infection—Doxorubicin—breast cancer	2.57e-05	0.000174	CcSEcCtD
Clonidine—Pain—Methotrexate—breast cancer	2.56e-05	0.000173	CcSEcCtD
Clonidine—Vomiting—Capecitabine—breast cancer	2.56e-05	0.000173	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.55e-05	0.000173	CcSEcCtD
Clonidine—Shock—Doxorubicin—breast cancer	2.55e-05	0.000173	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—breast cancer	2.54e-05	0.000172	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—breast cancer	2.54e-05	0.000172	CcSEcCtD
Clonidine—Rash—Capecitabine—breast cancer	2.53e-05	0.000172	CcSEcCtD
Clonidine—Insomnia—Epirubicin—breast cancer	2.53e-05	0.000171	CcSEcCtD
Clonidine—Dermatitis—Capecitabine—breast cancer	2.53e-05	0.000171	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—breast cancer	2.53e-05	0.000171	CcSEcCtD
Clonidine—Headache—Capecitabine—breast cancer	2.52e-05	0.00017	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—breast cancer	2.52e-05	0.00017	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—breast cancer	2.52e-05	0.00017	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—breast cancer	2.51e-05	0.00017	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—breast cancer	2.5e-05	0.000169	CcSEcCtD
Clonidine—Somnolence—Epirubicin—breast cancer	2.49e-05	0.000168	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—breast cancer	2.47e-05	0.000167	CcSEcCtD
Clonidine—Nausea—Docetaxel—breast cancer	2.47e-05	0.000167	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—breast cancer	2.47e-05	0.000167	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—breast cancer	2.45e-05	0.000166	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—breast cancer	2.43e-05	0.000165	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—breast cancer	2.42e-05	0.000164	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—breast cancer	2.42e-05	0.000164	CcSEcCtD
Clonidine—Fatigue—Epirubicin—breast cancer	2.41e-05	0.000163	CcSEcCtD
Clonidine—Pain—Epirubicin—breast cancer	2.4e-05	0.000162	CcSEcCtD
Clonidine—Constipation—Epirubicin—breast cancer	2.4e-05	0.000162	CcSEcCtD
Clonidine—Nausea—Capecitabine—breast cancer	2.39e-05	0.000162	CcSEcCtD
Clonidine—Urticaria—Methotrexate—breast cancer	2.38e-05	0.000161	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—breast cancer	2.37e-05	0.00016	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—breast cancer	2.37e-05	0.00016	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.36e-05	0.00016	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—breast cancer	2.34e-05	0.000159	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—breast cancer	2.33e-05	0.000157	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—breast cancer	2.31e-05	0.000156	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—breast cancer	2.31e-05	0.000156	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—breast cancer	2.3e-05	0.000156	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—breast cancer	2.29e-05	0.000155	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—breast cancer	2.25e-05	0.000152	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.24e-05	0.000151	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—breast cancer	2.23e-05	0.000151	CcSEcCtD
Clonidine—Urticaria—Epirubicin—breast cancer	2.23e-05	0.000151	CcSEcCtD
Clonidine—Pain—Doxorubicin—breast cancer	2.22e-05	0.00015	CcSEcCtD
Clonidine—Constipation—Doxorubicin—breast cancer	2.22e-05	0.00015	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—breast cancer	2.21e-05	0.00015	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—breast cancer	2.21e-05	0.00015	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—breast cancer	2.21e-05	0.000149	CcSEcCtD
Clonidine—Asthenia—Methotrexate—breast cancer	2.15e-05	0.000145	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—breast cancer	2.14e-05	0.000145	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—breast cancer	2.12e-05	0.000143	CcSEcCtD
Clonidine—Pruritus—Methotrexate—breast cancer	2.12e-05	0.000143	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—breast cancer	2.06e-05	0.00014	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—breast cancer	2.06e-05	0.000139	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—breast cancer	2.05e-05	0.000139	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—breast cancer	2.05e-05	0.000139	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—breast cancer	2.05e-05	0.000139	CcSEcCtD
Clonidine—Asthenia—Epirubicin—breast cancer	2.01e-05	0.000136	CcSEcCtD
Clonidine—Pruritus—Epirubicin—breast cancer	1.98e-05	0.000134	CcSEcCtD
Clonidine—Dizziness—Methotrexate—breast cancer	1.98e-05	0.000134	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—breast cancer	1.92e-05	0.00013	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—breast cancer	1.91e-05	0.000129	CcSEcCtD
Clonidine—Vomiting—Methotrexate—breast cancer	1.9e-05	0.000129	CcSEcCtD
Clonidine—Rash—Methotrexate—breast cancer	1.89e-05	0.000128	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—breast cancer	1.89e-05	0.000128	CcSEcCtD
Clonidine—Headache—Methotrexate—breast cancer	1.87e-05	0.000127	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—breast cancer	1.86e-05	0.000126	CcSEcCtD
Clonidine—Dizziness—Epirubicin—breast cancer	1.85e-05	0.000125	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—breast cancer	1.83e-05	0.000124	CcSEcCtD
Clonidine—Vomiting—Epirubicin—breast cancer	1.78e-05	0.000121	CcSEcCtD
Clonidine—Nausea—Methotrexate—breast cancer	1.78e-05	0.00012	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—breast cancer	1.77e-05	0.00012	CcSEcCtD
Clonidine—Rash—Epirubicin—breast cancer	1.77e-05	0.000119	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—breast cancer	1.76e-05	0.000119	CcSEcCtD
Clonidine—Headache—Epirubicin—breast cancer	1.75e-05	0.000119	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—breast cancer	1.71e-05	0.000116	CcSEcCtD
Clonidine—Nausea—Epirubicin—breast cancer	1.66e-05	0.000113	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—breast cancer	1.65e-05	0.000111	CcSEcCtD
Clonidine—Rash—Doxorubicin—breast cancer	1.63e-05	0.000111	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—breast cancer	1.63e-05	0.00011	CcSEcCtD
Clonidine—Headache—Doxorubicin—breast cancer	1.62e-05	0.00011	CcSEcCtD
Clonidine—Nausea—Doxorubicin—breast cancer	1.54e-05	0.000104	CcSEcCtD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—breast cancer	1.62e-06	1.79e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TYMS—breast cancer	1.62e-06	1.78e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ALB—breast cancer	1.62e-06	1.78e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SRC—breast cancer	1.61e-06	1.78e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CTNNB1—breast cancer	1.61e-06	1.78e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.61e-06	1.78e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NQO1—breast cancer	1.61e-06	1.78e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOS3—breast cancer	1.61e-06	1.77e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—breast cancer	1.6e-06	1.77e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NCOR1—breast cancer	1.6e-06	1.76e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.6e-06	1.76e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTM1—breast cancer	1.6e-06	1.76e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—breast cancer	1.59e-06	1.76e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1B—breast cancer	1.59e-06	1.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CD—breast cancer	1.58e-06	1.74e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—breast cancer	1.58e-06	1.74e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—breast cancer	1.57e-06	1.74e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1A—breast cancer	1.57e-06	1.74e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—breast cancer	1.57e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—breast cancer	1.57e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.57e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—breast cancer	1.57e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SERPINE1—breast cancer	1.56e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—breast cancer	1.56e-06	1.72e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2—breast cancer	1.56e-06	1.72e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—breast cancer	1.55e-06	1.72e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—breast cancer	1.55e-06	1.71e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.55e-06	1.71e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—breast cancer	1.55e-06	1.71e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NOS3—breast cancer	1.55e-06	1.71e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.54e-06	1.7e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CAV1—breast cancer	1.54e-06	1.7e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.54e-06	1.69e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK8—breast cancer	1.53e-06	1.69e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2—breast cancer	1.53e-06	1.69e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GPX1—breast cancer	1.53e-06	1.69e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—breast cancer	1.53e-06	1.69e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	1.53e-06	1.69e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.53e-06	1.68e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MDM2—breast cancer	1.52e-06	1.68e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RAF1—breast cancer	1.52e-06	1.68e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—breast cancer	1.52e-06	1.68e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.52e-06	1.67e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—JUN—breast cancer	1.52e-06	1.67e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.51e-06	1.67e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RELA—breast cancer	1.51e-06	1.67e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CB—breast cancer	1.51e-06	1.67e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CTNNB1—breast cancer	1.5e-06	1.66e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ERCC2—breast cancer	1.5e-06	1.66e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	1.5e-06	1.66e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—breast cancer	1.5e-06	1.65e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.49e-06	1.65e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOS3—breast cancer	1.49e-06	1.65e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—JUN—breast cancer	1.49e-06	1.65e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—breast cancer	1.49e-06	1.64e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK3—breast cancer	1.48e-06	1.64e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.48e-06	1.64e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.48e-06	1.64e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.48e-06	1.63e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—breast cancer	1.47e-06	1.63e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NCOA1—breast cancer	1.47e-06	1.62e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1A—breast cancer	1.47e-06	1.62e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—breast cancer	1.47e-06	1.62e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SRC—breast cancer	1.45e-06	1.61e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.45e-06	1.6e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.45e-06	1.6e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—STK11—breast cancer	1.45e-06	1.6e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.45e-06	1.6e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—breast cancer	1.44e-06	1.59e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.44e-06	1.59e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TGFB1—breast cancer	1.44e-06	1.59e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK8—breast cancer	1.43e-06	1.58e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—breast cancer	1.43e-06	1.58e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CB—breast cancer	1.43e-06	1.57e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	1.42e-06	1.57e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—breast cancer	1.42e-06	1.57e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—breast cancer	1.42e-06	1.57e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—breast cancer	1.42e-06	1.56e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.42e-06	1.56e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.42e-06	1.56e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—breast cancer	1.41e-06	1.56e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MTHFR—breast cancer	1.41e-06	1.56e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—breast cancer	1.41e-06	1.56e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.41e-06	1.56e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.41e-06	1.56e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.41e-06	1.55e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RELA—breast cancer	1.4e-06	1.55e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—breast cancer	1.4e-06	1.55e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.4e-06	1.55e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.4e-06	1.54e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.39e-06	1.54e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.38e-06	1.52e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.38e-06	1.52e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.38e-06	1.52e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.36e-06	1.51e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2—breast cancer	1.36e-06	1.5e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SRC—breast cancer	1.36e-06	1.5e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.35e-06	1.5e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—COMT—breast cancer	1.35e-06	1.49e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTP1—breast cancer	1.34e-06	1.48e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.34e-06	1.48e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SRC—breast cancer	1.34e-06	1.48e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—breast cancer	1.33e-06	1.47e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.33e-06	1.47e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—JUN—breast cancer	1.32e-06	1.46e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HMOX1—breast cancer	1.32e-06	1.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.32e-06	1.46e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—breast cancer	1.32e-06	1.46e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ITPR1—breast cancer	1.32e-06	1.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.32e-06	1.45e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.31e-06	1.45e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—breast cancer	1.31e-06	1.45e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CD—breast cancer	1.31e-06	1.44e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—breast cancer	1.3e-06	1.44e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—breast cancer	1.3e-06	1.44e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CAV1—breast cancer	1.3e-06	1.44e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.3e-06	1.44e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.3e-06	1.44e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.29e-06	1.43e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALB—breast cancer	1.29e-06	1.42e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.29e-06	1.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.29e-06	1.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.28e-06	1.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.28e-06	1.41e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.28e-06	1.41e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.28e-06	1.41e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ABCB1—breast cancer	1.27e-06	1.4e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.27e-06	1.4e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.27e-06	1.4e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.26e-06	1.39e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.25e-06	1.38e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK3—breast cancer	1.25e-06	1.38e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.25e-06	1.38e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TYMS—breast cancer	1.25e-06	1.38e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.24e-06	1.37e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—breast cancer	1.24e-06	1.36e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NOS3—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NCOR1—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTM1—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.23e-06	1.36e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	1.23e-06	1.35e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.22e-06	1.35e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—breast cancer	1.22e-06	1.34e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALB—breast cancer	1.22e-06	1.34e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TGFB1—breast cancer	1.21e-06	1.34e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.2e-06	1.33e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—breast cancer	1.2e-06	1.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.2e-06	1.32e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.2e-06	1.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.19e-06	1.32e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—breast cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SRC—breast cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—breast cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—breast cancer	1.18e-06	1.31e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GPX1—breast cancer	1.18e-06	1.3e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.17e-06	1.29e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.17e-06	1.29e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.16e-06	1.29e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NOS3—breast cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ERCC2—breast cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.16e-06	1.28e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.15e-06	1.26e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CB—breast cancer	1.14e-06	1.26e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—breast cancer	1.13e-06	1.25e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—breast cancer	1.13e-06	1.25e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—breast cancer	1.13e-06	1.24e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.11e-06	1.22e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.11e-06	1.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SRC—breast cancer	1.1e-06	1.22e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	1.09e-06	1.21e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MTHFR—breast cancer	1.09e-06	1.2e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—breast cancer	1.09e-06	1.2e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	1.08e-06	1.19e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.07e-06	1.18e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—breast cancer	1.07e-06	1.18e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—breast cancer	1.06e-06	1.18e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—breast cancer	1.06e-06	1.18e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—breast cancer	1.06e-06	1.17e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	1.06e-06	1.17e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.04e-06	1.15e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—breast cancer	1.04e-06	1.15e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	1.03e-06	1.14e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALB—breast cancer	1.03e-06	1.14e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—breast cancer	1.02e-06	1.13e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	1.02e-06	1.12e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	1.02e-06	1.12e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—breast cancer	1.01e-06	1.11e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAV1—breast cancer	1.01e-06	1.11e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—breast cancer	1e-06	1.11e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—breast cancer	1e-06	1.11e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—breast cancer	1e-06	1.1e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—breast cancer	9.89e-07	1.09e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	9.87e-07	1.09e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NOS3—breast cancer	9.85e-07	1.09e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—breast cancer	9.84e-07	1.09e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—breast cancer	9.84e-07	1.09e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—breast cancer	9.84e-07	1.09e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—breast cancer	9.8e-07	1.08e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—breast cancer	9.68e-07	1.07e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—breast cancer	9.67e-07	1.07e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—breast cancer	9.56e-07	1.06e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—breast cancer	9.41e-07	1.04e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—breast cancer	9.28e-07	1.02e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—breast cancer	9.2e-07	1.02e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—breast cancer	9.16e-07	1.01e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—breast cancer	9.15e-07	1.01e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—breast cancer	9.14e-07	1.01e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CB—breast cancer	9.09e-07	1e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—breast cancer	9.04e-07	9.98e-06	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	9.04e-07	9.98e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—breast cancer	9.01e-07	9.95e-06	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—breast cancer	9.01e-07	9.95e-06	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—breast cancer	8.74e-07	9.65e-06	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—breast cancer	8.69e-07	9.6e-06	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—breast cancer	8.45e-07	9.32e-06	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	8.4e-07	9.27e-06	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—breast cancer	8.36e-07	9.23e-06	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—breast cancer	8.31e-07	9.17e-06	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—breast cancer	8.2e-07	9.06e-06	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—breast cancer	8.12e-07	8.97e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CD—breast cancer	8.05e-07	8.89e-06	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—breast cancer	8e-07	8.83e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALB—breast cancer	7.95e-07	8.77e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—breast cancer	7.86e-07	8.67e-06	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—breast cancer	7.77e-07	8.58e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NOS3—breast cancer	7.6e-07	8.39e-06	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—breast cancer	7.52e-07	8.3e-06	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—breast cancer	7.44e-07	8.21e-06	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—breast cancer	7.38e-07	8.15e-06	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—breast cancer	7.1e-07	7.84e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CB—breast cancer	7.02e-07	7.75e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—breast cancer	6.95e-07	7.68e-06	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—breast cancer	6.94e-07	7.67e-06	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—breast cancer	6.86e-07	7.57e-06	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—breast cancer	6.54e-07	7.22e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—breast cancer	6.06e-07	6.69e-06	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—breast cancer	5.67e-07	6.26e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—breast cancer	5.54e-07	6.12e-06	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—breast cancer	5.35e-07	5.9e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—breast cancer	4.53e-07	5e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—breast cancer	4.28e-07	4.72e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—breast cancer	3.49e-07	3.86e-06	CbGpPWpGaD
